Biosketch: Marco Sandri is Full Professor of Pathology and Head of the Department of Biomedical Sciences at University of Padova. He received his M.D. degree and the residency in Clinical Pathology at the University of Padova. He carried out postdoctoral work in Alfred L Goldberg lab at Harvard Medical School, Boston. In 2005 and 2010 he was awarded by the prestigious Dulbecco Telethon career award prize and established his lab at Venetian Institute of Molecular Medicine in Padova. Marco Sandri has also an honorary position as Adjunct Professor at McGill University, Montreal, Canada from 2011. He got the prestigious ERC consolidator grant, he has been panel member of ERC consolidator program and is now a reviewer for the European Commission (ERC). In 2021, 2022, 2023 he got the award “Highly Cited Researcher”, which recognizes the true pioneers in their fields over the last decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in the Web of Science™. In 2023 he recieved the Alfredo Margreth prize for the Muscle Biology and Physiopathology conferred by National Academy of Lincei, the oldest scientific Academy in the world. He is particularly interested in understanding the signaling pathways that control muscle mass with a focus on the role of the ubiquitin-proteasome and autophagy-lysosome systems. He was the first to show a transcriptional-dependent regulation of autophagy and protein breakdown. His research has provided insights into mechanisms of regulation of these proteolytic systems and to metabolic adaptations to physical activity. His work has been obtained more than 39.000 citations (Scopus) and he has an h-index of 83. For his contribution to the regulation of protein breakdown, Marco Sandri was invited to give lectures in outstanding research centers, among them the Harvard Medical School in Boston, the Imperial College of London, the Institut Pasteur in Paris, the Oxford University, the Medical Research Council in Cambridge, the McGill University in Montreal, the University of Pennsylvania of Philadelphia, and many others. He is leader of the Padova unit of the PRIN 2022 Dissecting mechanisms that cause cancer cachexia
Roles: Spoke 2 co-leader, Spoke 2 WP2 and Task 2.5 leader
Contacts: marco.sandri@unipd.it
Website: https://www.vimm.it/scientific-board/marco-sandri/
Research interests